Document:

Exhibit 4.2

 

	RIGHTS CERTIFICATE #:	 	NUMBER OF RIGHTS

 

THE TERMS AND CONDITIONS OF THE RIGHTS OFFERING ARE SET FORTH
IN THE COMPANY'S PROSPECTUS DATED JANUARY, [*], 2017 (THE "PROSPECTUS") AND ARE INCORPORATED HEREIN BY REFERENCE. COPIES
OF THE PROSPECTUS ARE AVAILABLE UPON REQUEST FROM BROADRIDGE, INC., THE INFORMATION AGENT, BY EMAIL AT Shareholder@Broadridge.COM, BY TELEPHONE AT (855) 793-5068 OR BY MAIL AT BROADRIDGE, INC., 51 MERCEDES WAY, EDGEWOOD, NEW YORK 11717.

 

Second Sight Medical Products, Inc.

Incorporated under the laws of the State
of California

NON - TRANSFERABLE SUBSCRIPTION RIGHTS CERTIFICATE

Evidencing Non - Transferable Subscription
Rights to Purchase Units of Second Sight Medical Products, Inc.

each Unit consisting of one share of Common
Stock and one warrant representing the right to purchase one share of Common Stock

 

Subscription Price: to be determined as
set forth below

 

THE SUBSCRIPTION RIGHTS WILL EXPIRE IF NOT
EXERCISED ON OR BEFORE 5:00 P.M., NEW YORK TIME, ON [ ] __, 2017, UNLESS EXTENDED BY THE COMPANY

 

REGISTERED

OWNER:

 

THIS CERTIFIES THAT the registered owner
whose name is inscribed hereon is the owner of the number of non-transferable subscription rights (“Rights”) set forth
above. Each whole Right entitles the holder thereof to invest $0.47 for every share of Common Stock, no par value, of Second Sight
Medical Products, Inc., a California corporation, that the holder owns on the record date, at a subscription price (the “Subscription
Price”) of (i) $2.00 per Unit or (ii) the closing price of our shares as reported by Nasdaq on [    ], 2017, (the "Expiration
Date"), whichever is less, per whole Unit (the “Basic Subscription Right”), pursuant to a rights offering (the
“Rights Offering”), on the terms and subject to the conditions set forth in the Prospectus and the “Instructions
for Use of Subscription Rights Certificate” accompanying this Subscription Rights Certificate. Each Unit consists of one
share of common stock, no par value (“Common Stock”), and one warrant representing the right to purchase one
share of common stock at the Subscription Price. If any Units available for purchase in the Rights Offering are not purchased by
other holders of Rights pursuant to the exercise of their Basic Subscription Right (the “Over-Subscription Units”),
any Rights holder that exercises its Basic Subscription Right in full may purchase a number of Excess Units pursuant to the terms
and conditions of the Rights Offering (the “Over-Subscription Privilege”). The Rights represented by this Subscription
Rights Certificate may be exercised by completing Form 1 and any other appropriate forms on the reverse side hereof and by returning
the full payment of the subscription price for each Unit in accordance with the “Instructions for Use of Subscription Rights
Certificate” that accompany this Subscription Rights Certificate.

 

The undersigned acknowledges that the number
of Units that the undersigned may obtain by subscribing for units in this offering cannot be determined on the date subscription
of rights are exercised hereby, but that the undersigned will obtain the number of units equal to the result of dividing the accepted
dollar amount of investment by the Subscription Price on the Expiration Date.

 

This Subscription Rights Certificate is
not valid unless countersigned by the subscription agent and registered by the registrar.

 

Witness the signatures of the duly authorized
officers of Second Sight Medical Products, Inc.

 

Dated:

 

	 	 	 
	President	 	Secretary

 

     

     

    

  

DELIVERY OPTIONS FOR SUBSCRIPTION RIGHTS
CERTIFICATE

Delivery other than in the manner or to
the address listed below will not constitute valid delivery.

    

	By mail:*	By hand or overnight courier:
	 	 
	Broadridge Inc. 	Broadridge Inc.
	Attn: BCIS Re-Organization Dept. 	Attn: BCIS IWS
	P.O. Box 1317	51 Mercedes Way
	Brentwood, NY 11717-0693	Edgewood, NY 11717
	(855) 793-5068 (toll free)	 (855) 793-5068 (toll free)

 

*If your chosen delivery method is USPS
Priority Mail or USPS Registered Mail, you must utilize the overnight courier address.

 

     

     

    

  

PLEASE PRINT ALL INFORMATION CLEARLY AND
LEGIBLY.

 

	 	 	FORM 2-DELIVERY TO DIFFERENT ADDRESS
	 	 	 
	
        FORM 1-EXERCISE OF SUBSCRIPTION RIGHTS

         

        To invest and purchase Units pursuant to your Basic Subscription
        Right, please complete lines (a) and (c) and sign under Form 3 below. To invest and purchase Units pursuant to your Over-Subscription
        Right, please also complete line (b) and sign under Form 3 below. To the extent your investment exceeds Units that you are entitled
        under either the Basic Subscription Right or the Over-Subscription Right, you will be deemed to have elected to purchase the maximum
        number of Units for which you are entitled to under the Basic Subscription Right or Over-Subscription Right, as applicable.
	 	If you wish for the Common Stock and Warrants underlying your subscription rights, or a certificate representing unexercised subscription rights to be delivered to an address different from that shown on the face of this Subscription Rights Certificate, please enter the alternate address below, sign under Form 3 and have your signature guaranteed under Form 4.
	 	 
	 	 
	 	 
	 	 
	 	 
	 	FORM 3-SIGNATURE
	(a) EXERCISE OF BASIC SUBSCRIPTION RIGHT:	 	 
	 	 	 
	I apply to	invest ($0.47x shares owned)	=	$	 	TO SUBSCRIBE: I acknowledge that I have received the Prospectus for the rights offering and I hereby irrevocably invest the amount indicated under Form 1 above on the terms and conditions specified in the Prospectus. This Form 3 must be signed by the registered holder(s) exactly as their name(s) appear(s) on the certificate(s) or by person(s) authorized to sign on behalf of the registered holder(s) by documents transmitted herewith.
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 
	(b) EXERCISE OF OVER-SUBSCRIPTION RIGHT	 	(Holder Signature)
	 	 	 
		 	FORM 4-SIGNATURE GUARANTEE
	 	 	 
	If you have exercised your Basic Subscription Right in full and wish to purchase additional Units pursuant to your Over-Subscription Right:	 	This form must be completed if you have completed any portion of Form 2.
	 	 	 
	I apply for	Over-Subscription of:	 	$_________	 	Signature
	 	 	 	 	 	Guaranteed:	 
	 	 	 	 	 	 	(Name of Bank or Firm)
	 	 	 
	(c) Total Amount of Payment Enclosed = $________	 	 
	 	 	 
	METHOD OF PAYMENT (CHECK ONE)	 	By:	 
	 	 	 	(Signature of Officer)
	 ̈	Check or bank draft payable to “Broadridge, Inc., as Subscription Agent for Second Sight Medical Products, Inc.”	 	
         

        IMPORTANT: The subscriber’s signature(s) should be guaranteed
        by an eligible guarantor institution (bank, stock broker, savings & loan association or credit union) with membership in an
        approved signature guarantee medallion program pursuant to Securities and Exchange Commission Rule 17Ad-15.

	 	 
	 ̈	Wire transfer of immediately available funds directly to the account maintained by Broadridge, Inc., as Subscription Agent, for purposes of accepting subscriptions in this Rights Offering to [Bank], for credit to for Broadridge, Inc., Second Sight Medical Products, Inc., ABA No. [           ], further credit to Account Number [          ], with reference to the rights holder's name.	 

 

FOR INSTRUCTIONS ON THE USE OF SECOND SIGHT
MEDICAL PRODUCTS, INC. SUBSCRIPTION RIGHTS CERTIFICATES, CONSULT BROADRIDGE, INC., THE INFORMATION AGENT, BY EMAIL AT SHAREHOLDER@BROADRIDGE.COM,
BY TELEPHONE AT (   ) -  OR BY MAIL AT BROADRIDGE, INC., (855) 793-5068 OR BY MAIL AT BROADRIDGE, INC., 51
MERCEDES WAY, EDGEWOOD, NEW YORK 11717.Exhibit 4.4

 

WARRANT AGREEMENT

 

This Warrant Agreement
made as of January    , 2017 is between Second Sight Medical Products, Inc., a California corporation, with offices
at 12744 San Fernando Road, Suite 400, Sylmar, California 91342 (the “Company”), and VStock Transfer, LLC, with offices
at 18 Lafayette Place, Woodmere, New York (the “Warrant Agent”).

 

WHEREAS, the Company
is engaged in a shareholder rights offering and an offering, on a best efforts, no minimum basis, (collectively the “Offering”)
of units (“units“) consisting of shares of common stock of the Company, no par value (“Common Stock”),
and warrants to purchase shares of Common Stock of the Company and, in connection therewith, has determined to issue and deliver
up to 15 million Warrants to shareholders (collectively, the “Shareholders”) who purchase the Units in the Offering,
each such Warrant evidencing the right of the holder thereof to purchase one share of Common Stock at strike price equal to the
Subscription Price in the Offering per share (“Warrant Price”), subject to adjustment as described herein (the “Warrants”);

 

WHEREAS,
the Company has filed with the Securities and Exchange Commission (the “Commission”) a registration statement on Form
S-1 (File No. 333-215463 the “Registration Statement”) (as the same may be amended from time to time) for the
registration, under the Securities Act of 1933, as amended, of the shares of Common Stock and the Warrants to be sold to Shareholders
in the Offering and the shares of Common Stock underlying the Warrants (the “Warrant Shares”);

 

WHEREAS, the Company
desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the
issuance, registration, transfer, exchange, redemption and exercise of the Warrants;

 

WHEREAS, the Company
desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the
respective rights, limitation of rights and immunities of the Company, the Warrant Agent and the holders of the Warrants (each,
a “Record Holder”) or if the Warrants are held in “street name”, a Participant (as defined below) or a
designee appointed by such Participant; and

 

WHEREAS, all acts
and things have been done and performed which are necessary to make the Warrants, when executed on behalf of the Company and countersigned
by or on behalf of the Warrant Agent, as provided herein, the legally valid and binding obligations of the Company, and to authorize
the execution and delivery of this Warrant Agreement.

 

NOW, THEREFORE, in
consideration of the mutual agreements herein contained, the parties hereto agree as follows:

 

1.           Appointment
of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company for the Warrants, and the
Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions set forth
in this Agreement.

 

     

     

    

 

		2.	Warrants.

 

2.1          Form
of Warrant. Each Warrant shall be (a) issued in registered form only, (b) in substantially the form of Exhibit A attached
hereto, the provisions of which are incorporated herein, (c) signed by, or bear the facsimile signature of, the Chairman of the
Board or, the Chief Executive Officer or the President, and the Treasurer, Secretary or Assistant Secretary of the Company, and
(d) signed by the Warrant Agent. In the event the person whose facsimile signature has been placed upon any Warrant shall have
ceased to serve in the capacity in which such person signed the Warrant before such Warrant is issued, it may be issued with the
same effect as if he or she had not ceased to be such at the date of issuance. All of the Warrants shall initially be represented
by one or more book-entry certificates (each, a “Book-Entry Warrant Certificate”).

 

2.2          Effect
of Countersignature. Unless and until countersigned by the Warrant Agent pursuant to this Agreement, a Warrant shall be invalid
and of no effect and may not be exercised by the holder thereof. Warrant certificates shall be dated the date of countersignature
by the Warrant Agent.

 

2.3          Registration.

 

2.3.1           Warrant
Register. The Warrant Agent shall maintain books (the “Warrant Register”) for the registration of the original
issuance and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall
issue and register the Warrants in the names of the respective holders thereof in such denominations and otherwise in accordance
with instructions delivered to the Warrant Agent by the Company. To the extent the Warrants are eligible for the book entry and
depository services of The Depository Trust Company (“DTC Eligible”) as of the date of issuance (the “Issuance
Date”), all of the Warrants shall be represented by one or more Book-Entry Warrant Certificates deposited with The Depository
Trust Company (“Depository”) and registered in the name of Cede & Co., a nominee of the Depository. Ownership
of beneficial interests in the Book-Entry Warrant Certificates shall be shown on, and the transfer of such ownership shall be
effected through, records maintained (i) by the Depository or its nominee for each Book-Entry Warrant Certificate; (ii) by institutions
that have accounts with the Depository (such institution, with respect to a Warrant in its account, a “Participant”);
or (iii) directly on the book-entry records of the Warrant Agent with respect only to owners of interests represented by such
direct registration. If the Warrants are not DTC Eligible as of the Issuance Date or the Depository subsequently ceases to make
its book-entry settlement system available for the Warrants, DTC will instruct the Warrant Agent regarding making other arrangements
for book-entry settlement within 10 days after the Depository ceases to make its book-entry settlement available. In the event
that DTC does not make alternative arrangements for book-entry settlement within 10 days or the Warrants are not eligible for,
or it is no longer necessary to have the Warrants available in, book-entry form, the Warrant Agent shall provide written instructions
to the Depository to deliver to the Warrant Agent for cancellation each Book-Entry Warrant Certificate, and DTC shall instruct
the Warrant Agent to deliver to the Depository definitive certificates (“Warrant Certificates”) in physical form evidencing
such Warrants. Such Warrant Certificates shall be in substantially the form annexed hereto as Exhibit A.

 

     

     

    

 

2.3.2           Beneficial
Owner; Record Holder. The term “beneficial owner” shall mean any person in whose name ownership of a beneficial
interest in the Warrants evidenced by a Book-Entry Warrant Certificate is recorded in the records maintained by the Depository
or its nominee. Prior to due presentment to the Warrant Agent for registration of transfer of any Warrant, the Company and the
Warrant Agent may deem and treat the person in whose name such Warrant is registered in the Warrant Register as the absolute owner
of such Warrant and of each Warrant represented thereby (notwithstanding any notation of ownership or other writing on the Warrant
Certificate (as defined below) made by anyone other than the Company or the Warrant Agent), for the purpose of any exercise thereof,
and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.

 

2.3.3           Uncertificated
Warrants. Notwithstanding the foregoing and anything else herein to the contrary, the Warrants may be issued in uncertificated
form.

 

		3.	Terms
                                         and Exercise of Warrants.

 

3.1          Warrant
Price. Each Warrant shall, when countersigned by the Warrant Agent, entitle the Record Holder thereof, subject to the provisions
of such Warrant and of this Warrant Agreement, to purchase from the Company the number of shares of Common Stock and at the price,
subject to the adjustments provided in Section 4 hereof. The term “Warrant Price” as used in this Warrant Agreement
refers to the price per share at which Common Stock may be purchased at the time a Warrant is exercised.

 

3.2          Duration
of Warrants. A Warrant may be exercised only during the period (“Exercise Period”) commencing on the date of issuance
and ending on [ ], 2022  (“Expiration Date”). Each Warrant not exercised on or before the Expiration
Date shall become void, and all rights thereunder and all rights in respect thereof under this Agreement shall cease at 5:00 p.m.
Eastern time on the Expiration Date.

 

3.3          Exercise
of Warrants.

 

3.3.1           Payment.
Subject to the provisions of the Warrant and this Warrant Agreement, a Warrant, when countersigned by the Warrant Agent, may be
exercised by the Record Holder thereof by surrendering it, at the office of the Warrant Agent, or at the office of its successor
as Warrant Agent, with the Election to Purchase, as set forth in the Warrant, duly executed, and by paying to the Company in full,
in lawful money of the United States, in cash, good certified check or good bank draft payable to the order of the Company (or
as otherwise agreed to by the Company), the Warrant Price for each full share of Common Stock as to which the Warrant is exercised
and any and all applicable taxes due in connection with the exercise of the Warrant, the exchange of the Warrant for the Common
Stock, and the issuance of the Common Stock. No ink-original Election to Purchase shall be required, nor shall any medallion guarantee
(or other type of guarantee or notarization) of any Election to Purchase form be required; provided, however,
that if the Company’s transfer agent is not participating in the Depository’s Fast Automated Securities Transfer Program
and the Record Holder requests that the shares of Common Stock be issued or registered to a holder other than the Record Holder,
then an ink-original Election to Purchase and a medallion guarantee shall be required. The Record Holder shall not be required
to deliver the original Warrant in order to effect an exercise hereunder. In no event shall the Record Holder of any Warrant be
entitled to “net cash settle” the Warrant.

 

     

     

    

 

3.3.2            Issuance
of Certificates. Assuming funds for exercise of the Warrant are paid on or before the second Trading Day following the date
of receipt by the Warrant Agent of the Election to Purchase and that the Registration Statement, including the Prospectus, or
another registration statement and current prospectus, covering the Warrants and the Warrant Shares is effective, then on or before
the third Trading Day following the date upon which the Company has received the Warrant Price, the Company shall cause its transfer
agent to (i) provided that the transfer agent is participating in the Depository’s Fast Automated Securities
Transfer Program, credit such aggregate number of shares of Common Stock to which the Holder is entitled pursuant to such exercise
to the Holder’s or its designee’s balance account with the Depository through its Deposit/Withdrawal at Custodian
System, or (ii) if the transfer agent is not participating in the Depository’s Fast Automated Securities Transfer Program,
issue and deliver to the Holder, or at the Holder’s instruction pursuant to the delivered Election to Purchase, the Holder’s
agent or designee, in each case pursuant to this clause (ii), sent by reputable overnight courier to the address specified in
the applicable Election to Purchase, a certificate, registered in the Company’s share register in the name of the Holder
or its designee (as indicated in the applicable Election to Purchase), for the number of shares of Common Stock to which the Holder
is entitled pursuant to such exercise. While any Warrants remain outstanding, the Company shall maintain a transfer agent that
participates in the Depository’s Fast Automated Securities Transfer Program. “Trading Day” means any day that
the primary trading market on which the Common Stock is listed or quoted is open for trading.”

 

3.3.3           Valid
Issuance. All shares of Common Stock issued upon the proper exercise or surrender of a Warrant in conformity with this Agreement
shall be validly issued, fully paid and nonassessable.

 

3.3.4           Date
of Issuance. Each person in whose name any certificate for the Common Stock is issued or to whom shares of Common Stock are
credited to such person’s account at the Depository shall for all purposes be deemed to have become the holder of record
of such Common Stock as of the time that a duly executed Election to Purchase is delivered in accordance with Section 3.3.1, assuming
payment of the Warrant Price is made within two Trading Days after the delivery of the Election to Purchase, and if the payment
of the Warrant Price is not made within two Trading Days after the delivery of the Election to Purchase, the Holder shall be deemed
to have become the holder of record of such Common Stock on the first Trading Day after the date on which the Warrant Price has
been paid, irrespective of the date of delivery of such certificate or the date the shares of Common Stock are credited to such
person’s account at the Depository, except that, if the date of such delivery and/or payment is a date when the stock transfer
books of the Company are closed, such person shall be deemed to have become the holder of such shares at the close of business
on the next succeeding date on which the stock transfer books are open.

 

     

     

    

 

		4.	Adjustments.

 

4.1           Events
Requiring Adjustment. The Warrant Price and number of Warrant Shares issuable upon exercise of this Warrant are subject to
adjustment from time to time as set forth in this Section 4.

 

4.1.1.          Stock
Dividends; Subdivisions; Combinations. If the Company, at any time while the Warrants are outstanding, (i) pays a stock dividend
on its Common Stock or otherwise makes a distribution on any class of capital stock that is payable in shares of Common Stock,
(ii) subdivides its outstanding shares of Common Stock into a larger number of shares of Common Stock, (iii) combines its outstanding
shares of Common Stock into a smaller number of shares of Common Stock or (iv) issues by reclassification of shares of capital
stock any additional shares of Common Stock of the Company, then in each such case the Warrant Price shall be multiplied by a
fraction, the numerator of which shall be the number of shares of Common Stock outstanding immediately before such event and the
denominator of which shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made
pursuant to clause (i) of this paragraph shall become effective immediately after the record date for the determination of shareholders
entitled to receive such dividend or distribution, provided, however, that if such record date shall have been fixed and such
dividend is not fully paid on the date fixed therefor, the Warrant Price shall be recomputed accordingly as of the close of business
on such record date and thereafter the Warrant Price shall be adjusted pursuant to this Section as of the time of actual payment
of such dividends. Any adjustment pursuant to clause (ii) or (iii) of this Section shall become effective immediately after the
effective date of such subdivision or combination.

 

4.1.2           Property
Distributions. If the Company, at any time while the Warrants are outstanding, distributes to all holders of Common Stock
for no consideration (i) evidences of its indebtedness, (ii) any security (other than a distribution of Common Stock covered by
the preceding paragraph) or (iii) rights or warrants to subscribe for or purchase any security, or (iv) any other asset (in each
case, “Distributed Property”), then, upon any exercise of this Warrant that occurs after the record date  fixed
for determination of stockholders entitled to receive such distribution, the Holder shall be entitled to receive, in addition
to the Warrant Shares otherwise issuable upon such exercise (if applicable), the Distributed Property that such Holder would have
been entitled to receive in respect of such number of Warrant Shares had the Holder been the record holder of such Warrant Shares
immediately prior to such record date without regard to any limitation on exercise contained therein.

 

     

     

    

 

4.1.3           Fundamental
Transactions . If, at any time while the Warrants are outstanding (i) the Company effects any merger or consolidation
of the Company with or into another Person, in which the Company is not the surviving entity or the shareholders of the Company
immediately prior to such merger or consolidation do not own, directly or indirectly, at least 50% of the voting power of the
surviving entity immediately after such merger or consolidation, (ii) the Company effects any sale to another Person of all or
substantially all of its assets in one or a series of related transactions, (iii) pursuant to any tender offer or exchange offer
(whether by the Company or another Person), holders of capital stock who tender shares representing more than 50% of the voting
power of the capital stock of the Company and the Company or such other Person, as applicable, accepts such tender for payment,
(iv) the Company consummates a stock purchase agreement or other business combination (including, without limitation, a reorganization,
recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than the 50%
of the voting power of the capital stock of the Company or (v) the Company effects any reclassification of the Common Stock or
any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities,
cash or property (other than as a result of a subdivision or combination of shares of Common Stock covered by Section 4.1.1 above)
(in any such case, a “Fundamental Transaction”), then following such Fundamental Transaction the Holder shall have
the right to receive, upon exercise of this Warrant, the same amount and kind of securities, cash or property as it would have
been entitled to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental
Transaction, the holder of the number of Warrant Shares then issuable upon exercise in full of the Warrant without regard to any
limitations on exercise contained herein (the “Alternate Consideration”). The Company shall not effect any Fundamental
Transaction in which the Company is not the surviving entity or the Alternate Consideration includes securities of another Person
unless prior to or simultaneously with the consummation thereof, any successor to the Company, surviving entity or other Person
(including any purchaser of assets of the Company) shall assume the obligation to deliver to the Holder such Alternate Consideration
as, in accordance with the foregoing provisions, the Holder may be entitled to receive, and the other obligations under this Warrant.
“Person” means any natural person, corporation, firm, joint venture, partnership, limited liability company, association,
enterprise, trust or other entity or organization, or any government or political subdivision or any agency, department or instrumentality
thereof.

 

4.1.4           Adjustment
to Number of Warrant Shares. Simultaneously with any adjustment to the Warrant Price pursuant to Section 4.1.1, the number
of Warrant Shares that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately, so that
after such adjustment the aggregate Warrant Price payable hereunder for the increased or decreased number of Warrant Shares shall
be the same as the aggregate Warrant Price in effect immediately prior to such adjustment.

 

4.1.5           Method
of Calculation. All calculations under this Section 4 shall be made to the nearest cent or the nearest whole share, as the
case may be. For purposes of this Section 4, any calculation of the number of shares of Common Stock deemed to be issued and outstanding
as of a given date shall not include treasury shares, if any. Notwithstanding anything to the contrary in this Section 4, no adjustment
in the Warrant Price shall be required unless such adjustment would require an increase or decrease of at least 1% in such price;
provided, however, that any adjustments which by reason of the immediately preceding sentence are not required to be made shall
be carried forward and taken into account in any subsequent adjustment.

 

     

     

    

 

4.1.6           Notification
at the Request of Holder. Upon the occurrence of each adjustment pursuant to this Section 4, the Company at its expense will,
at the written request of the Holder, promptly compute such adjustment, in good faith, in accordance with the terms of the Warrant
and prepare a certificate setting forth such adjustment, including a statement of the adjusted Warrant Price and adjusted number
or type of Warrant Shares or other securities issuable upon exercise of this Warrant (as applicable), describing the transactions
giving rise to such adjustments and showing in detail the facts upon which such adjustment is based. Upon written request, the
Company will promptly deliver a copy of each such certificate to the Holder.

 

4.1.7           Notice
to Holder and Warrant Agent. If, while this Warrant is outstanding, the Company (i) declares a dividend or any other distribution
of cash, securities or other property in respect of its Common Stock, including, without limitation, any granting of rights or
warrants to subscribe for or purchase any capital stock of the Company or any subsidiary or (ii) authorizes or approves or enters
into any material definitive agreement contemplating any Fundamental Transaction or (iii) authorizes, approves or solicits stockholder
approval for any Fundamental Transaction, including authorizing the voluntary dissolution, liquidation or winding up of the affairs
of the Company, then, except if such notice and the contents thereof shall be deemed to constitute material non-public information,
the Company shall deliver to the Holder and to the Warrant Agent a notice of such transaction at least 10 days prior to the applicable
record or effective date on which a Person would need to hold Common Stock in order to participate in or vote with respect to
such transaction; provided, however, that the failure to deliver such notice or any defect therein shall not affect the validity
of the corporate action required to be described in such notice. In addition, if while this Warrant is outstanding, the Company
enters into any material definitive agreement contemplating, or solicits, stockholder approval for any Fundamental Transaction
contemplated by Section 4.1.3, other than a Fundamental Transaction under clause (iii) of Section 4.1.3, the Company shall deliver
to the Holder and to the Warrant Agent a notice of such Fundamental Transaction at least 15 days prior to the date such Fundamental
Transaction is consummated and shall upon such consummation provide written confirmation to the Warrent Agent of any such adjustments.
Failure to give such notice, or any defect therein, shall not affect the legality or validity of such event.

 

4.1.8           No
Fractional Shares. Notwithstanding any provision contained in this Warrant Agreement to the contrary, the Company shall not
issue fractional shares upon exercise of Warrants. If, by reason of any adjustment made pursuant to this Section 4, the holder
of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share,
the Company shall, upon such exercise, round down to the nearest whole number the number of the shares of Common Stock to be issued
to the Warrant holder.

 

4.1.9           Form
of Warrant. The form of Warrant need not be changed because of any adjustment pursuant to this Section 4, and Warrants issued
after such adjustment may state the same Warrant Price and the same number of shares as is stated in the Warrants initially issued
pursuant to this Agreement. However, the Company may, at any time, in its sole discretion, make any change in the form of Warrant
that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter issued or countersigned,
whether in exchange or substitution for an outstanding Warrant or otherwise, may be in the form as so changed.

 

     

     

    

 

		5.	Transfer
                                         and Exchange of Warrants.

 

5.1           Registration
of Transfer. The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant into the Warrant
Register, upon surrender of such Warrant for transfer, properly endorsed with signatures properly guaranteed and accompanied by
appropriate instructions for transfer. Upon any such transfer, a new Warrant representing an equal aggregate number of Warrants
shall be issued and the old Warrant shall be cancelled by the Warrant Agent. The Warrants so cancelled shall be delivered by the
Warrant Agent to the Company from time to time upon the Company’s request.

 

5.2           Procedure
for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent, together with a written request for exchange
or transfer, and, thereupon, the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested by the Record
Holder of the Warrants so surrendered, representing an equal aggregate number of Warrants; provided, however, that, in the event
a Warrant surrendered for transfer bears a restrictive legend, the Warrant Agent shall not cancel such Warrant and shall issue
new Warrants in exchange therefor until the Warrant Agent has received an opinion of counsel for the Company stating that such
transfer may be made and indicating whether the new Warrants must also bear a restrictive legend.

 

5.3           Fractional
Warrants. The Warrant Agent shall not be required to effect any registration of transfer or exchange which will result in
the issuance of a warrant certificate for a fraction of a warrant.

 

5.4           Warrant
Execution and Countersignature. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance with the
terms of this Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5, and the Company, whenever
required by the Warrant Agent, will supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose.

 

	 	6.	Other
    Provisions Relating to Rights of Holders of Warrants.

 

6.1           No
Rights as Stockholder. A Warrant does not entitle the Record Holder thereof to any of the rights of a stockholder of the Company,
including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights to vote
or to consent or to receive notice as stockholders in respect of the meetings of stockholders or the election of directors of
the Company or any other matter.

 

6.2           Lost,
Stolen Mutilated or Destroyed Warrants. If any Warrant is lost, stolen, mutilated or destroyed, the Company and the Warrant
Agent may, on such terms as to indemnity or bond or otherwise as Warrant Agent may in accord with its general practice impose
(which terms shall, in the case of a mutilated Warrant, include the surrender thereof), issue a new Warrant of like denomination,
tenor and date as the Warrant so lost, stolen, mutilated or destroyed. Any such new Warrant shall constitute a substitute contractual
obligation of the Company, whether or not the allegedly lost, stolen, mutilated or destroyed Warrant shall be at any time enforceable
by anyone.

 

     

     

    

 

6.3           Reservation
of Common Stock. The Company shall at all times reserve and keep available a number of its authorized but unissued shares
of Common Stock that will be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Warrant
Agreement.

 

6.4           Registration
of Common Stock. The Company registered the Warrants and the Warrant Shares in the Registration Statement. The Company will
use its reasonable best efforts to maintain the effectiveness of the Registration Statement and the current status of the Prospectus
or to file and maintain the effectiveness of another registration statement and another current prospectus covering the Warrants
and the Warrant Shares at any time that the Warrants are exercisable. In addition, the Company agrees to use its reasonable best
efforts to register the Warrants and Warrant Shares under the blue sky laws of the states of residence of the Record Holders to
the extent an exemption from such registration is not available.

 

		7.	Redemption.

 

7.1           Right
of Redemption. Not less than all of the outstanding Warrants may be redeemed, at the option of the Company, at any time after
at any time 24 months after the date of issuance and prior to the Expiration Date, upon not less than 30 days’ prior written
notice of redemption to each Warrant holder, and if, and only if, (i) the closing price of the common stock equals or exceeds
200% of the Subscription Price (subject to adjustment proportionate to any adjustment to the Warrant Price pursuant to Section 4),
subject to adjustment, per share, for 15 consecutive trading days ending prior to the notice of redemption to the Registered Holders
and there is an effective registration statement covering the shares of Common Stock issuable upon exercise of the Warrants current
and available, and (ii) all of our independent directors vote in favor of a redemption, at the office of the Warrant Agent, upon
the notice referred to in Section 7.2, at the price of $0.01 per Warrant (subject to adjustment proportionate
to any adjustment to the Warrant Price pursuant to Section 4) (the “Redemption Price”).

 

7.2           Date
Fixed for, and Notice of, Redemption. In the event the Company shall elect to redeem all of the Warrants pursuant to Section 7.1 (the
“Redeemable Warrants”), the Company shall fix a date for the redemption. Notice of redemption shall
be mailed by first class mail, postage prepaid, by the Company not less than 30 days prior to the date fixed for redemption to
the Registered Holders of the Redeemable Warrants at their last addresses as they shall appear on the registration books. Any
notice mailed in the manner herein provided shall be conclusively presumed to have been duly given on the date sent whether or
not the Registered Holder received such notice. A copy of the notice of redemption and of exercise of right of redemption shall
be provided to the Warrant Agent concurrently with the mailing to holders of Warrants.

 

7.3           Exercise
After Notice of Redemption. The Redeemable Warrants may be exercised for cash in accordance with Section 3.3.1 of
this Warrant Agreement at any time after notice of redemption shall have been given by the Company pursuant to Section 7.2 hereof
and prior to the time and date fixed for redemption. On and after the redemption date, the record holders of the Redeemable Warrants
shall have no further rights except to receive the Redemption Price upon surrender of the Redeemable Warrants.

 

     

     

    

 

		8.	Concerning
                                         the Warrant Agent and Other Matters.

 

8.1          Payment
of Taxes. The Company will, from time to time, promptly pay all taxes and charges that may be imposed upon the Company or
the Warrant Agent in respect of the issuance or delivery of shares of Common Stock upon the exercise of Warrants, but the Company
shall not be obligated to pay any transfer taxes in respect of the Warrants or such shares.

 

8.2          Resignation,
Consolidation, or Merger of Warrant Agent.

 

8.2.1           Appointment
of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and be discharged
from all further duties and liabilities hereunder after giving 60 days’ notice in writing to the Company. If the office
of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint, in writing, a
successor Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of thirty
(30) days after it has been notified in writing of such resignation or incapacity by the Warrant Agent or by the holder of the
Warrant (who shall, with such notice, submit his, her or its Warrant for inspection by the Company), then the holder of any Warrant
may apply to the Supreme Court of the State of New York for the County of New York or the appointment of a successor Warrant Agent.
Any successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation organized and existing
under the laws of the State of New York, in good standing and have its principal office in the State of New York, and be authorized
under such laws to exercise corporate trust powers and be subject to supervision or examination by federal or state authorities.
After appointment, any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities, duties and
obligations of its predecessor Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further
act or deed; but, if for any reason it becomes necessary or appropriate, the predecessor Warrant Agent shall execute and deliver,
at the expense of the Company, an instrument transferring to such successor Warrant Agent all the authority, powers, and rights
of such predecessor Warrant Agent hereunder; and, upon request of any successor Warrant Agent, the Company shall make, execute,
acknowledge, and deliver any and all instruments in writing for more fully and effectually vesting in and confirming to such successor
Warrant Agent all such authority, powers, rights, immunities, duties and obligations.

 

8.2.2           Notice
of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof
to the predecessor Warrant Agent and the transfer agent for the Common Stock not later than the effective date of any such appointment.

 

8.2.3           Merger
or Consolidation of Warrant Agent. Any corporation into which the Warrant Agent may be merged or with which it may be consolidated
or any corporation resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor
Warrant Agent under this Warrant Agreement without any further act on the part of the Company or the Warrant Agent.

 

     

     

    

 

8.3         
Fees and Expenses of Warrant Agent.

 

8.3.1           Remuneration.
The Company agrees to pay the Warrant Agent reasonable remuneration for its services as Warrant Agent hereunder as
set forth on Exhibit B hereto and will reimburse the Warrant Agent upon demand for all expenditures that the
Warrant Agent may reasonably incur in the execution of its duties hereunder.

 

8.3.2           Further
Assurances. The Company agrees to perform, execute, acknowledge and deliver, or cause to be performed, executed, acknowledged
and delivered, all such further and other acts, instruments and assurances as may reasonably be required by the Warrant Agent
for the carrying out or performing of the provisions of this Warrant Agreement.

 

8.4
         Liability of Warrant Agent.

 

8.4.1           Reliance
on Company Statement. Whenever, in the performance of its duties under this Warrant Agreement, the Warrant Agent shall deem
it necessary or desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action
hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be
conclusively proved and established by a statement signed by the Chief Executive Officer, Chief Financial Officer or Chairman
of the Board of the Company and delivered to the Warrant Agent. The Warrant Agent may rely upon such statement for any action
taken or suffered in good faith by it pursuant to the provisions of this Warrant Agreement.

 

8.4.2           Indemnity.
The Warrant Agent shall be liable hereunder only for its own gross negligence, willful misconduct or bad faith. The Company agrees
to indemnify the Warrant Agent and save it harmless against any and all liabilities, including judgments, costs and reasonable
counsel fees, for anything done or omitted by the Warrant Agent in the execution of this Warrant Agreement, except as a result
of the Warrant Agent’s negligence, willful misconduct or bad faith.

 

8.4.3           Exclusions.
The Warrant Agent shall have no responsibility with respect to the validity of this Warrant Agreement or with respect to the validity
or execution of any Warrant (except its countersignature thereof); nor shall it be responsible for any breach by the Company of
any covenant or condition contained in this Warrant Agreement or in any Warrant; nor shall it be responsible to make any adjustments
required under the provisions of Section 4 hereof or responsible for the manner, method or amount of any such adjustment or the
ascertaining of the existence of facts that would require any such adjustment; nor shall it, by any act hereunder, be deemed to
make any representation or warranty as to the authorization or reservation of any shares of Common Stock to be issued pursuant
to this Warrant Agreement or any Warrant or as to whether any shares of Common Stock will when issued be valid and fully paid
and nonassessable.

 

     

     

    

 

8.5           Acceptance
of Agency. The Warrant Agent hereby accepts the agency established by this Warrant Agreement and agrees to perform the same
upon the terms and conditions herein set forth and, among other things, shall account promptly to the Company with respect to
Warrants exercised and concurrently account for, and pay to the Company, all moneys received by the Warrant Agent for the purchase
of shares of the Company’s Common Stock through the exercise of Warrants.

 

		9.	Miscellaneous
                                         Provisions.

 

9.1           Successors.
All the covenants and provisions of this Warrant Agreement by or for the benefit of the Company or the Warrant Agent shall bind
and inure to the benefit of their respective successors and assigns.

 

9.2           Notices.
Any notice, statement or demand authorized by this Warrant Agreement to be given or made by the Warrant Agent or by the holder
of any Warrant to or on the Company shall be delivered by hand or sent by registered or certified mail or overnight courier service,
addressed (until another address is filed in writing by the Company with the Warrant Agent) as follows:

 

Second Sight Medical Products, Inc.

12744 San Fernando Road, Suite 400

Sylmar, California 91342

Attn: Thomas B. Miller, Chief Financial Officer

 

Any notice, statement or demand authorized
by this Warrant Agreement to be given or made by the holder of any Warrant or by the Company to or on the Warrant Agent shall
be delivered by hand or sent by registered or certified mail or overnight courier service, addressed (until another address is
filed in writing by the Warrant Agent with the Company), as follows:

 

VStock Transfer, LLC

18 Lafayette Place

Woodmere, NY 11598

Attn: Warrant Department

 

Any notice, sent pursuant to this Warrant
Agreement shall be effective, if delivered by hand, upon receipt thereof by the party to whom it is addressed, if sent by overnight
courier, on the next business day of the delivery to the courier, and if sent by registered or certified mail on the third day
after registration or certification thereof

 

     

     

    

 

9.3           Applicable
Law. The validity, interpretation, and performance of this Warrant Agreement and of the Warrants shall be governed in all
respects by the laws of the State of New York, without giving effect to conflict of laws. The Company hereby agrees that any action,
proceeding or claim against it arising out of or relating in any way to this Warrant Agreement shall be brought and enforced in
the courts of the State of New York or the United States District Court for the Southern District of New York, and irrevocably
submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive
jurisdiction and that such courts represent an inconvenient forum. Any such process or summons to be served upon the Company may
be served by transmitting a copy thereof by registered or certified mail, return receipt requested, postage prepaid, addressed
to it at the address set forth in Section 9.2 hereof. Such mailing shall be deemed personal service and shall be legal and binding
upon the Company in any action, proceeding or claim.

 

9.4           Examination
of the Warrant Agreement. A copy of this Warrant Agreement shall be available at all reasonable times at the office of the
Warrant Agent for inspection by the Record Holder of any Warrant. The Warrant Agent may require any such holder to submit his,
her or its Warrant for inspection.

 

9.5           Counterparts-
Facsimile Signatures. This Warrant Agreement may be executed in any number of counterparts, and each of such counterparts
shall, for all purposes, be deemed to be an original, and all such counterparts shall together constitute one and the same instrument.
Facsimile signatures shall constitute original signatures for all purposes of this Warrant Agreement.

 

9.6           Effect
of Headings. The section headings herein are for convenience only and are not part of this Warrant Agreement and shall not
affect the interpretation thereof

 

9.7           Amendments.

 

9.7.1           This
Agreement and any Warrant certificate may be amended by the parties hereto by executing a supplemental warrant agreement (a “Supplemental
Agreement”), without the consent of any of the Warrant holders, for the purpose of (i) curing any ambiguity, or curing,
correcting or supplementing any defective provision contained herein, or making any other provisions with respect to matters or
questions arising under this agreement that is not inconsistent with the provisions of this agreement or the Warrant certificates,
(ii) evidencing the succession of another corporation to the Company and the assumption by any such successor of the covenants
of the Company contained in this agreement and the Warrants, (iii) evidencing and providing for the acceptance of appointment
by a successor Warrant Agent with respect to the Warrants, (iv) adding to the covenants of the Company for the benefit of the
holders or surrendering any right or power conferred upon the Company under this Agreement, or (v) amending this Agreement and
the Warrants in any manner that the Company may deem to be necessary or desirable and that will not adversely affect the interests
of the Warrant holders in any material respect.

 

9.7.2           The
Company and the Warrant Agent may amend this Warrant Agreement and the Warrants by executing a Supplemental Agreement with the
consent of the holders of not fewer than a majority of the unexercised Warrants affected by such amendment, for the purpose of
adding any material provisions to or changing in any material manner or eliminating any of the material provisions of this Agreement
or of modifying in any manner the rights of the holders under this Warrant Agreement; provided, however, that, without the consent
of each of the Warrant holders affected thereby, no such amendment may be made that (i) changes the Warrants so as to reduce the
number of shares purchasable upon exercise of the Warrants or so as to increase the Warrant Price (other than as provided
by Section 4), (ii) shortens the period of time during which the Warrants may be exercised, (iii) otherwise adversely affects
the exercise rights of the holders in any material respect, or (iv) reduces the number of unexercised Warrants the holders of
which must consent for amendment of this Agreement or the Warrants.

 

     

     

    

 

9.8          Severability.
This Warrant Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall
not affect the validity or enforceability of this Warrant Agreement or of any other term or provision hereof. Furthermore, in
lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of
this Warrant Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid
and enforceable.

 

IN WITNESS WHEREOF, this Warrant Agreement
has been duly executed by the parties hereto as of the day and year first above written.

 

	 	SECOND SIGHT MEDICAL PRODUCTS,
    INC.
	 	 	 
	 	By:	 
	 	 	Thomas B. Miller, Chief Financial Officer
	 	 	 
	 	VSTOCK TRANSFER, LLC
	 	 	 
	 	By:	 
	 	 	Yoel Goldfeder, Chief Executive Officer

 

     

     

    

 

EXHIBIT A

 

Form of Warrant

 

FORM OF WARRANT CERTIFICATE

 

Number

 

Warrants

 

THIS WARRANT SHALL BE VOID IF NOT EXERCISED
PRIOR TO

 

THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED
FOR

 

IN THE WARRANT AGREEMENT DESCRIBED BELOW

 

SECOND SIGHT MEDICAL PRODUCTS, INC.

 

Incorporated Under the Laws of the State
of California

 

CUSIP [_____________]

 

Warrant Certificate

 

This Warrant Certificate
certifies that __________________, or its registered assigns, is the record holder of warrant(s) (the “Warrants” and
each, a “Warrant”) to purchase shares of Common Stock, no par value per share (“Common Stock”), of Second
Sight Medical Products, Inc., a California corporation (the “Company”). Each Warrant entitles the holder,
upon exercise during the period set forth in the Warrant Agreement referred to below, to receive from the Company that number
of fully paid and nonassessable shares of Common Stock as set forth below, at the exercise price (the “Exercise Price”)
as determined pursuant to the Warrant Agreement, payable in lawful money of the United States of America, subject to the conditions
set forth herein and in the Warrant Agreement. Defined terms used in this Warrant Certificate but not defined herein shall have
the meanings given to them in the Warrant Agreement (as defined on the reverse hereof). This Warrant is subject to call and redemption
commencing two years after date of initial issuance on February   , 2017, as set forth within the Warrant Agreement.

 

Each Warrant is initially
exercisable for one fully paid and non-assessable share of Common Stock. The number of shares of Common Stock issuable upon exercise
of the Warrants is subject to adjustment upon the occurrence of certain events set forth in the Warrant Agreement.

 

The initial Exercise
Price per share of Common Stock for any Warrant is equal to the Subscription Price of one Unit sold in the Offering, as defined
in the Warrant Agreement. The Exercise Price is subject to adjustment upon the occurrence of certain events set forth in the Warrant
Agreement.

 

     

     

    

 

Subject to the conditions
set forth in the Warrant Agreement, the Warrants may be exercised only during the Exercise Period and to the extent not exercised
by the end of such Exercise Period, such Warrants shall become void.

 

Reference is hereby
made to the further provisions of this Warrant Certificate set forth on the reverse hereof and such further provisions shall for
all purposes have the same effect as though fully set forth at this place.

 

This Warrant Certificate
shall not be valid unless countersigned by the Warrant Agent, as such term is used in the Warrant Agreement.

 

This Warrant Certificate
shall be governed by and construed in accordance with the internal laws of the State of New York, without regard to conflicts
of laws principles thereof.

 

IN WITNESS WHEREOF, the parties
hereto have caused this Warrant Certificate to be duly executed as of the date first above written.

 

	 	SECOND SIGHT MEDICAL PRODUCTS,
    INC.
	 	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:
	 	 	 
	 	VSTOCK
    TRANSFER, LLC as Warrant Agent
	 	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:

 

[Signature Page to Warrant Certificate]

 

     

     

    

 

[Form of Warrant Certificate]

 

[Reverse]

 

The Warrants evidenced
by this Warrant Certificate are part of a duly authorized issue of Warrants entitling the holder on exercise to receive shares
of Common Stock and are issued or to be issued pursuant to a Warrant Agreement dated as of [     ], 2017 (the
“Warrant Agreement”), duly executed and delivered by the Company to VStock Transfer, LLC, a [ ] limited
liability trust company, as warrant agent (the “Warrant Agent”), which Warrant Agreement is hereby incorporated
by reference in and made a part of this instrument and is hereby referred to for a description of the rights, limitation of rights,
obligations, duties and immunities thereunder of the Warrant Agent, the Company and the holders (the words “holders”
or “holder” meaning the Record Holders or Record Holder) of the Warrants. A copy of the Warrant Agreement may be obtained
by the holder hereof upon written request to the Company. Defined terms used in this Warrant Certificate but not defined herein
shall have the meanings given to them in the Warrant Agreement.

 

Warrants may be
exercised at any time during the Exercise Period set forth in Section 3.2 of the Warrant Agreement but are subject to a call of
redemption on not less than 30 days’ written notice following the two year anniversary of issuance as set forth in Section
7 of the Warrant Agreement.

 

The Warrant Agreement
provides that upon the occurrence of certain events the number of shares of Common Stock issuable upon exercise of the Warrants
set forth on the face hereof may, subject to certain conditions, be adjusted. If, upon exercise of a Warrant, the holder thereof
would be entitled to receive a fractional interest in a share of Common Stock, the Company shall, upon exercise, round down to
the nearest whole number of shares of Common Stock to be issued to the holder of the Warrant.

 

Warrant Certificates,
when surrendered at the principal corporate trust office of the Warrant Agent by the Record Holder thereof in person or by legal
representative or attorney duly authorized in writing, may be exchanged, in the manner and subject to the limitations provided
in the Warrant Agreement, but without payment of any service charge, for another Warrant Certificate or Warrant Certificates of
like tenor evidencing in the aggregate a like number of Warrants.

 

Upon due presentation
for registration of transfer of this Warrant Certificate at the office of the Warrant Agent, a new Warrant Certificate or Warrant
Certificates of like tenor and evidencing in the aggregate a like number of Warrants shall be issued to the transferee(s) in exchange
for this Warrant Certificate, subject to the limitations provided in the Warrant Agreement, without charge except for any tax
or other governmental charge imposed in connection therewith.

 

The Company and
the Warrant Agent may deem and treat the Record Holder(s) hereof as the absolute owner(s) of this Warrant Certificate (notwithstanding
any notation of ownership or other writing hereon made by anyone), for the purpose of any exercise hereof, of any distribution
to the holder(s) hereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice
to the contrary. Neither the Warrants nor this Warrant Certificate entitles any holder hereof to any rights of a stockholder of
the Company.

 

     

     

    

 

Election to Purchase

 

(To Be Executed Upon Exercise of Warrant)

 

The undersigned
hereby irrevocably elects to exercise the right, represented by this Warrant Certificate, to receive shares of Common Stock and
herewith tenders payment for such shares to the order of Second Sight Medical Products, Inc. (the “Company”) in the
amount of $__________________ in accordance with the terms hereof. The undersigned requests that a certificate for such shares
be registered in the name of _____________________________, whose address is ______________________________________________________________,
and that such shares be delivered to ______________________________, whose address is ______________________________________________________________________.
If said number of shares is less than all of the shares of Common Stock purchasable hereunder, the undersigned requests that a
new Warrant Certificate representing the remaining balance of such shares be registered in the name of ______________________________________________,
whose address is ______________________________________________________, and that such Warrant Certificate be delivered to ____________________________________________,
whose address is _______________________________________________________________.

 

Date: ____________________________________

 

	 	 
	 	 
	 	 
	 	Print
    Name
	 	 
	 	Address:	 
	 	 
	 	 
	 	 
	 	Tax
    Identification Number

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}]]